Current Pharmaceutical Design , 2020 Cytoprotective Effects on the Gut: Orally administered BPC-157 has shown promise in protecting the mucosal lining of the stomach and intestines , though oral bioavailability is debated
Notably, calcium electroporation-a non-thermal ablation method-has shown efficacy in localized PCa treatment
(2) molecular dynamics simulated annealing restraining FOXO4 FH (without flexible regions) harmonically to its template structure (using a non-crystallographic force constant of 10,000 kcal mol 1 2 ), with additional dihedral angle restraints from 1 H, 15 N, and 13 C chemical shifts using TALOS-N 56 , hydrogen bond restraints (region p53 residues 48-55
J Physiol (Paris) 87:313327, 1993 Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Rotkvic I, Turkovic B, Jagic V, Mildner B, Duvnjak M, Danilovic Z: Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl 4 administration